We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Whole Body Vibration Therapy in Participants With MS Related Balance Deficits

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00510523
Recruitment Status : Completed
First Posted : August 2, 2007
Last Update Posted : May 3, 2013
Sponsor:
Information provided by (Responsible Party):
Dennis Enix, DC, MBA, Logan College of Chiropractic

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in participants with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.

Condition or disease Intervention/treatment Phase
Multiple Sclerosis Device: Whole Body Vibration machine Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Whole Body Vibration Therapy in Participants With MS Related Balance Deficits
Study Start Date : October 2006
Study Completion Date : November 2007

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. NeuroCom Balance Master
  2. SF-EMG Nerve conduction velocity test
  3. Berg balance score

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Logan student, staff, or faculty or general public with a minimal of 2 year history of diagnosed Multiple Sclerosis (MS)

Exclusion Criteria:

  • Visual or vestibular condition that would affect balance
  • Non-Ms related systemic illness that would have an adverse effect on balance
  • Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes
  • Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates
  • Acute thrombosis
  • Severe migraine, epilepsy
  • Serious cardiovascular disease, wearing a pacemaker
  • Any Spinal manipulation within 48 hours
  • Acute disc herniation, discopathy or spondylolysis
  • Prescription or herbal muscle stimulants, relaxants, etc. that could affect balance
  • Any implanted device or prosthesis or intrauterine IUD type of device
  • Pregnancy
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00510523


Locations
Layout table for location information
United States, Missouri
Logan University, College of Chiropractic
Chesterfield, Missouri, United States, 63017
Logan University, College of Chirpractic
Chesterfield, Missouri, United States, 63017
Sponsors and Collaborators
Logan College of Chiropractic
Investigators
Layout table for investigator information
Principal Investigator: Dennis Enix, DC, MBA Logan College of Chiropractic
Principal Investigator: Dennis Enix, DC, MBA Logan University
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
Responsible Party: Dennis Enix, DC, MBA, Assistant Professor, Logan College of Chiropractic
ClinicalTrials.gov Identifier: NCT00510523    
Other Study ID Numbers: RD0731060030
First Posted: August 2, 2007    Key Record Dates
Last Update Posted: May 3, 2013
Last Verified: May 2013
Keywords provided by Dennis Enix, DC, MBA, Logan College of Chiropractic:
MS
Balance
Multiple Sclerosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Multiple Sclerosis
Sclerosis
Pathologic Processes
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
 Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases